Early prediction of antipsychotic response in schizophrenia

American Journal of Psychiatry

Volumn 160, Issue 11, 2003, Pages 2063-2065

  Correll, Christoph U ^a   Malhotra, Anil K ^b   Kaushik, Saurabh ^b   McMeniman, Marjorie ^b   Kane, John M ^b  

^a ZUCKER HILLSIDE HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUPHENAZINE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RATING SCALE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; BRIEF PSYCHIATRIC RATING SCALE; FEMALE; FLUPHENAZINE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

EID: 1842435000     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.160.11.2063     Document Type: Article

References (19)

1. American Psychiatric Association: Practice Guideline for the Treatment of Patients With Schizophrenia. Am J Psychiatry 1997; 154(April suppl)
2. Treatment of schizophrenia 1999: the expert consensus guideline series. J Clin Psychiatry 1999; 60(suppl 11):3-80
3. American Academy of Child and Adolescent Psychiatry: Summary of the practice parameters for the assessment and treatment of children and adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry 2000; 39:1580-1582
4. Canadian Psychiatric Association: Canadian clinical practice guidelines for the treatment of schizophrenia. Can J Psychiatry 1998; 43(suppl 2):25S-40S
5. Miller AL, Chiles JA, Chiles JK, Crismon ML, Rush AJ, Shon SP. The Texas Medication Algorithm Project (TMAP) schizophrenia algorithms. J Clin Psychiatry 1999; 60:649-657
6. Lehman AF, Steinwachs DM: Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophr Bull 1998; 24:1-10
7. Osser DN, Sigadel R: Short-term inpatient pharmacotherapy of schizophrenia. Harv Rev Psychiatry 2001; 9:89-104
8. Stern RG, Kahn RS, Harvey PD, Amin F, Apter SH, Hirschowitz J: Early response to haloperidol treatment in chronic schizophrenia. Schizophr Res 1993; 10:165-171
9. Zemlan FP, Thienhaus OJ, Garver DL: Length of psychiatric hospitalization and prediction of antipsychotic response. Prog Neuropsychopharmacol Biol Psychiatry 1990; 14:13-24
10. Rifkin A, Doddi S, Karajgi B, Wachspress M, Boppana V: Neuroleptic treatment and prediction of response. Psychopharmacol Bull 1988; 24:169-171
11. Bartko G, Herczeg I, Bekesy M: Predicting outcome of neuroleptic treatment on the basis of subjective response and early clinical improvement. J Clin Psychiatry 1987; 48:363-365
12. Nedopil N, Pflieger R, Ruther E: The prediction of acute response, remission and general outcome of neuroleptic treatment in acute schizophrenic patients. Pharmacopsychiatria 1983; 16:201-205
13. May PR, Van Putten T, Yale C: Predicting outcome of antipsychotic drug treatment from early response. Am J Psychiatry 1980; 137:1088-1089
14. Gaebet W, Pietzcker A, Ulrich G, Schley J, Muller-Oerlinghausen B: Predictors of neuroleptic treatment response in acute schizophrenia: results of a treatment study with perazine. Pharmacopsychiatry 1988; 21:384-386
15. Kinon BJ, Kane JM, Johns C, Perovich R, Ismi M, Koreen A, Weiden P: Treatment of neuroleptic-resistant schizophrenic relapse. Psychopharmacol Bull 1993; 29:309-314
16. Overall JE, Gorham DR: The Brief Psychiatric Rating Scale. Psychol Rep 1962; 10:799-812
17. Headlund JL, Vieweg BW. The Brief Psychiatric Rating Scale (BPRS): a comprehensive review. J Operational Psychiatry 1980; 11:48-65
18. Kinon BJ, Kane JM, Chakos M, Munne R: Possible predictors of neuroleptic-resistant schizophrenic relapse: influence of negative symptoms and acute extrapyramidal side effects. Psychopharmacol Bull 1993; 29:365-369
19. Leucht S, Pitschel-Walz G, Abraham D, Kissling W: Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo: a meta-analysis of randomized controlled trials. Schizophr Res 1999; 35:51-68